Behandling af knæet osteoarthritis

Symptoms Of Arthritis Symptomerne på arthritis

The arthritis symptoms you experience can differ depending on the type of arthritis you have. Den arthritis symptomer du oplever kan variere afhængigt af arthritis, du har. .....

It sounds like something out of medieval times. Det lyder som noget ud af middelalderen. Using leeches to treat every disease and condition known to man. Brug af igler til at behandle alle sygdomme og tilstand, man kender. But as it turns out leeches are actually very powerful for treating a wide variety of ailments including knee osteoarthritis. Men som det viser sig, igler er faktisk meget stærkt for at behandle en lang række lidelser, herunder knæ osteoarthritis.

Knee osteoarthritis is a degenerative joint disease that results in the breakdown of the cartilage between the joints in the knees. Knæet osteoarthritis er en degenerative joint sygdom, der resulterer i en opdeling af brusk mellem leddene i knæ. This leads to pain, loss of range of motion and bone damage. Dette fører til smerter, tab af vifte af motion og knogleskader. There appears to be several origins of knee osteoarthritis including joint deformity, repeated injury, or excess weight. Der synes at være flere oprindelser af knæet osteoarthritis herunder fælles deformitet, gentagen skade, eller en for stor vægt. There is no cure for osteoarthritis so the focus is on treatments for the pain and reduction of continued damage to the joint. Der er ingen kur mod slidgigt så fokus ligger på behandlingsformer for smerter og reduktion af de fortsatte forringelser af joint.

And this is where leeches come in. Leeches secrete morphine, a potent pain killer. Og det er her, igler komme i. igler sekret morfin, en potent smertestillende medicin. Leeches also secrete an anticoagulant which improves blood flow to the area where the leeches are applied and an anti-inflammatory. Igler også udelukke en antikoagulant som forbedrer blodtilførslen til det område, hvor igler er anvendt, og en anti-inflammatorisk. Since inflammation is responsible for the symptoms of osteoarthritis, researchers believe that leeches might relieve pain in patients with osteoarthritis. Da betændelse er ansvarlig for symptomer på slidgigt, forskere mener, at igler kan lindre smerter hos patienter med slidgigt.

The US Food and Drug Administration (FDA) classify leeches as medical devices and has approved them for microsurgery. Den amerikanske Food and Drug Administration (FDA) klassificerer igler som medicinsk udstyr og har godkendt dem for mikrokirurgien. The FDA is also involved in the regulation of the transport and sale of leeches. FDA er også involveret i reguleringen af transport og salg af igler. In Germany there has been an estimated 70,000 treatments a year over the last few years with four to five used for each treatment. I Tyskland har der været en anslået 70.000 behandlinger om året gennem de seneste par år med fire-fem anvendes for hver behandling. Most of these treatments have been aimed at pain reduction in knee osteoarthritis. De fleste af disse behandlinger har været rettet mod smerte reduktion i knæ osteoarthritis.

Several studies have been conducted regarding the use of leeches for treating knee osteoarthritis. Flere undersøgelser har været gennemført med hensyn til brug af igler til behandling af knæet osteoarthritis.

One study, reported in the Annals of the Rheumatic Diseases, focused on 16 patients with an average age 68. En undersøgelse, rapporteret i Annals af gigtsygdomme, fokuserede på 16 patienter med en gennemsnitsalder 68. These patients had experienced persistent knee pain for more than six months. Disse patienter havde haft vedvarende knæ smerter i mere end seks måneder. None had suffered any knee injuries and all had x-ray evidence of osteoarthritis. Ingen havde lidt nogen knæ-skader og alle havde x-ray tegn på slidgigt. These patients were already treating their knee osteoarthritis with physical therapy, relaxation, diet and exercise. Disse patienter var allerede behandler deres knæ osteoarthritis med fysisk terapi, afslapning, kost og motion.

In this study, part of the group was provided traditional treatment and the rest were treated with leeches. I denne undersøgelse var den del af koncernen blev givet traditionel behandling og resten blev behandlet med igler. Four leeches were applied to the knee for 80 minutes. Fire igler blev anvendt på knæ for 80 minutter. Pain levels were measured three days before and 28 day after the treatment. Smerter niveauer blev målt tre dage før og 28 dage efter behandling. The results were rapid. Resultaterne var hurtig. Treatment with leeches resulted in pain relief after three days and continued through the 28 day test period. Behandling med igler resulteret i smertelindring efter tre dage og fortsatte gennem de 28 dages testperiode. The patients who received traditional treatment did not experience relief. De patienter, der fik traditionel behandling ikke har erfaring relief. There were no side effects noted from the leeches and the patients reported that the initial leech bite was mildly painful. Der var ingen bivirkninger bemærkes fra igler og patienter rapporterede, at den oprindelige igle bid var mildt smertefuld.

A larger study was conducted involving 51 patients age 40 and above with knee osteoarthritis with high pain. En større undersøgelse blev udført som involverer 51 patienter i en alder af 40 og derover med knæet osteoarthritis med stor smerte. Four to six leeches were applied to the affected knee and were allowed to remain until they detached themselves, which took about 70 minutes. Fire til seks igler blev anvendt til de ramte knæ og fik lov til at forblive indtil de udsendte selv, der tog omkring 70 minutter. Then the patients rested the knee for 12 hours. Så de patienter hvile knæet i 12 timer. Researchers then measured the patients’ pain, stiffness and range of motion after 3, 7, 28, and 91 days. Forskere derefter måles patientens smerter, stivhed og vifte af forslag efter 3, 7, 28, og 91 dage.

The results were similar to the smaller study. Resultaterne blev i lighed med de mindre undersøgelse. The patients receiving leech therapy reported less pain, less stiffness, better function, and fewer total osteoarthritis symptoms through the full 91 days that the researchers followed them. De patienter, der fik igle terapi rapporteret mindre smerter, mindre stivhed, bedre funktion, og færre samlede osteoarthritis symptomer gennem hele 91 dage, at forskere fulgt dem.

These studies give hope for alternative treatments of knee osteoarthritis for reducing pain and increasing mobility. Disse undersøgelser giver håb for alternative behandlinger af knæet osteoarthritis for at mindske smerter og øget mobilitet. In order to properly validate these studies additional research needs to be conducted over a longer period of time. For at validere disse undersøgelser yderligere forskning skal gennemføres over en længere periode. But it appears that leeches do provide relief to knee osteoarthritis sufferers. Men det ser ud til, at igler gøre yde nødhjælp til knæet osteoarthritis syge.

For current Osteoarthritis news and research check our Osteoarthritis Blog Posts. For nuværende Slidgigt nyheder og forskning kontrollere vores Slidgigt blogindlæg.

FDA advisory committee to dscuss PMA for Genzyme's Synvisc-One FDA rådgivende udvalg til dscuss PMA for Genzyme's Synvisc-One

Genzyme Corporation has announced that its Premarket Approval application supplement for Synvisc-One will be discussed this Tuesday, December 9th, at a public meeting of the FDA's Orthopaedic and Rehabilitation ... ... Genzyme Corporation har annonceret, at firmaets Premarket Godkendelse ansøgning supplement til Synvisc-One vil blive drøftet denne tirsdag 9 december, på et offentligt møde i FDA's ortopædi og genoptræning ... ...

FDA Advisory Committee Recommends Approval of Bausch & Lomb Besifloxacin Anti-Infective Eye Drop FDA Rådgivende Udvalg anbefaler godkendelse af Bausch & Lomb Besifloxacin antiinfektiøs øjendråber

Dec 5, 2008 - Genzyme Corporation today announced that its Premarket Approval application supplement for Synvisc-One will be discussed this Tuesday, December 9th, at a public meeting of the FDA's Orthopaedic ... ... 5 december 2008 - Genzyme Corporation dag annonceret, at firmaets Premarket Godkendelse ansøgning supplement til Synvisc-One vil blive drøftet denne tirsdag 9 december, på et offentligt møde i FDA's Ortopædiske ... ...

FDA Advisory Committee To Discuss Genzyme's Synvisc-One PMA On... FDA rådgivende udvalg for at drøfte Genzyme's Synvisc-one PMA om ...

Main Category: Pain / Anesthetics Also Included In: Bones / Orthopaedics Article Date: 08 Dec 2008 - 2:00 PST Genzyme Corporation today announced that its Premarket Approval application supplement for ... ... Main Kategori: Smerte / Anesthetics også medtaget i: Ben / Ortopædkirurgi artikel Dato: 08 december 2008 - 2:00 PST Genzyme Corporation dag annonceret, at firmaets Premarket Godkendelse ansøgning supplement til ... ...

Pozen, Inc. Announces Positive Top Line Results for Its PN 400 Phase 3 Trials Pozen, Inc. annoncerer positive top line resultater for sin PN 400 fase 3 forsøgene

POZEN Inc. , today announced positive Phase 3 trial results for its PN 400 product candidate conducted by POZEN under an agreed Special Protocol Assessment with the FDA. ... POZEN Inc., i dag annonceret positive fase 3 forsøget resultater for sin PN 400 produkt kandidat foretages af POZEN under et aftalt særlige protokol Vurdering med FDA. ...

Treatment for Knee Osteoarthritis Behandling af knæet osteoarthritis